Status:
COMPLETED
Antibiotic Loaded Cement After TKA
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Total Knee Arthoplasty
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will provide us with clear information about the postoperative concentration of antibiotic reached in synovial fluid, thereby helping surgeons to determine if concentration could potentiall...
Eligibility Criteria
Inclusion
- All participants undergoing cemented primary total knee arthroplasty (TKA) who are 18 years or older.
Exclusion
- Withdrawal of informed consent,
- allergy to any of the study medications or to bone cement,
- use of antibiotics within 4 weeks before collecting the samples (not including perioperative antimicrobial prophylaxis),
- high risk of infection,
- history of peri-articular injections for multimodal pain management.
Key Trial Info
Start Date :
June 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05429671
Start Date
June 20 2022
End Date
November 30 2023
Last Update
April 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107